Impact of Surotomycin on the Gut Microbiota of Healthy Volunteers in a Phase 1 Clinical Trial

Antimicrobial Agents and Chemotherapy
Diane M CitronEllie J C Goldstein

Abstract

Clostridium difficile-associated diarrhea has been associated with disruption of the normal intestinal microbiota, particularly theBacteroides fragilisgroup andPrevotellaspecies. Surotomycin is a bactericidal cyclic lipopeptide in development for treatment ofClostridium difficile-associated diarrhea that has selective and potent activity againstC. difficileand other Gram-positive bacteria and a minimal impact on intestinal Gram-negative organisms. The impacts of ascending doses of surotomycin on major organism groups in the gut microbiota of healthy volunteers were evaluated during a randomized, double-blind, placebo-controlled, multiple-dose phase 1 study. Thirty volunteers were randomized into 3 cohorts, using a 4:1 ratio, to receive 250 mg, 500 mg, or 1,000 mg of surotomycin, or placebo, twice daily for 14 days. Stool samples collected at baseline (days 0 and 1) and at the end of treatment (days 13 to 15) were cultured quantitatively. TheB. fragilisgroup, theBacteroides/Prevotellagroup, andEnterobacteriaceaewere also quantified by quantitative real-time PCR. Baseline and end-of-treatment stool samples showed 1- to 2-log10CFU/g reductions in total bacterial counts for most volunteers. Various decreases in clostridial,Lactobac...Continue Reading

References

May 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel M MusherRichard J Hamill
May 18, 2006·Emerging Infectious Diseases·L Clifford McDonaldDaniel B Jernigan
Nov 14, 2006·Nucleic Acids Research·Alexander LoyMatthias Horn
Jun 30, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Fred A ZarMelinda B Davis
Jan 18, 2008·The Journal of Infectious Diseases·Ju Young ChangVincent B Young
Feb 7, 2008·Emerging Infectious Diseases·Matthew D RedelingsLaurene Mascola
Apr 9, 2008·Emerging Infectious Diseases·Florian BurckhardtTim Eckmanns
Feb 5, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Denise GravelUNKNOWN Canadian Nosocomial Infection Surveillance Program
Apr 3, 2009·World Journal of Gastroenterology : WJG·Perry Hookman, Jamie S Barkin
Apr 5, 2011·American Journal of Infection Control·Shigeki FujitaniA Rekha Murthy
Jul 7, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michelle M NerandzicCurtis J Donskey
Jul 7, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas J LouieWalter Krulicki
Jul 18, 2012·Antimicrobial Agents and Chemotherapy·Carmela T M MascioJared A Silverman
Oct 8, 2013·Nature Reviews. Immunology·Charlie G Buffie, Eric G Pamer

❮ Previous
Next ❯

Citations

Jun 30, 2016·The Journal of Antibiotics·Mark S ButlerMatthew A Cooper
Jul 14, 2016·Expert Review of Anti-infective Therapy·Eric T SlaytonTimothy E Long
Sep 20, 2016·Biochemical Pharmacology·Manuel FerrerAndrés Moya
Dec 3, 2016·Infectious Diseases and Therapy·Csaba FehérJosep Mensa
Jun 22, 2017·Experimental Dermatology·Jae-Hui NamWon-Serk Kim
May 2, 2018·Frontiers in Medicine·Nicola PetrosilloMaria Adriana Cataldo
Jan 31, 2017·Current Opinion in Gastroenterology·Eugénie BassèresKevin W Garey
Aug 17, 2021·AMB Express·Lulu YangGuven Ozdemir

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
T BerganS B Thorsteinsson
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
A J MatuteI M Hoepelman
Reviews of Infectious Diseases
C E NordG Stiernstedt
© 2022 Meta ULC. All rights reserved